Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CENOBAMATE for Adjuvant therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 22 adverse event reports in the FDA FAERS database where CENOBAMATE was used for Adjuvant therapy.

Most Reported Side Effects for CENOBAMATE

Side Effect Reports % Deaths Hosp.
Seizure 1,544 27.4% 21 381
Product dose omission issue 1,229 21.8% 9 175
Fatigue 608 10.8% 2 82
Somnolence 588 10.4% 2 100
Dizziness 486 8.6% 3 98
Off label use 376 6.7% 8 99
Product use issue 364 6.5% 0 41
Fall 323 5.7% 3 127
Headache 301 5.3% 0 32
Wrong technique in product usage process 268 4.8% 1 60
Feeling abnormal 237 4.2% 1 36
Gait disturbance 223 4.0% 0 48
Balance disorder 200 3.5% 1 43
Drug interaction 185 3.3% 2 63
Memory impairment 181 3.2% 3 26

Other Indications for CENOBAMATE

Epilepsy (2,230) Seizure (1,763) Product used for unknown indication (1,573) Partial seizures (460) Focal dyscognitive seizures (81) Generalised tonic-clonic seizure (75) Temporal lobe epilepsy (51) Petit mal epilepsy (35) Lennox-gastaut syndrome (31) New onset refractory status epilepticus (21)

Other Drugs Used for Adjuvant therapy

BREXPIPRAZOLE (2,296) CYCLOPHOSPHAMIDE (236) FLUOROURACIL (218) EPIRUBICIN (206) ARIPIPRAZOLE (171) CAPECITABINE (120) ZOLEDRONIC ACID (89) OXALIPLATIN (75) DOCETAXEL (65) LETROZOLE (64)

Related Pages

CENOBAMATE Full Profile All Adjuvant therapy Drugs CENOBAMATE Demographics CENOBAMATE Timeline